The serum fructosamine concentration at patients with diabetes mellitus

HealthMED

Volumn 4, Issue 1, 2010, Pages 132-137

  Serdarevic, N ^a   Pepic, E ^a   Musanovic, J ^a   Pleho Kapic, A ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Diabetes mellitus; Fructosamine; Glucose; Lipids

Indexed keywords

EID: 77949475737     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Pettiti D.B., Contreas R. Randomized trial fructosamine home monitoring in patients with diabetes. Efective Clinical Practice 2001; 4(1):18-23
2. Lothar T.: Labor und Diagnose TH - Books, Frankfurt/ Main 2000, pp 123-152.
3. Guillausseau P-J, Charles M-A, Godard V, Timsit J, Chanson P, Paolaggi F et al. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients. Diabetes Research, 1990. 13:127-31
4. Lothar T.: Labor und Diagnose TH - Books, Frankfurt/ Main 1992, pp 177-184.
5. Salway J.G.: Medical Biochemistry at a Glance, Blackwell Publishing Ltd, Massachusetts 02148-5020, USA 2008: pp 76-77.
6. www.personalmd.com/news/a1999030402.shtml : Fructosamine Levels Linked To Heart Diseas. SOURCE: American Journal of Epidemiology 1999; 149:471-75
7. Pleho -Kapic A, Beslagic R, Pepic E, Fajkic A. Level of cholesterol anlipoprotein fractions in cardiovascular diseases, HealthMED,2008;2(3): 154-161
8. Pepic E, Fajkic A, Pleho-Kapic A, Dzubur A, Musanovic J. Plasma level of high-density lipoprotein-HDL and low-density lipoprotein - LDL in patients wit ischemic stroke, HealthMED, 2009; 2 (4): 467-472
9. Operator's Manuel, Boehringer Mannheim, 2004.
10. Kunst A., Draeger B., Ziegenhorn J., UV- methods with hexokinase and glucose-6-phosphate dehydrogenase, Methods of Enzymatic Analysis Vol VI, Bergmeyer, HU,Eu, Verlag Chemie, Deerfield, FL 1983, pp 163-172
11. Stadtman TC, Methods in Enzymology, Vol III, Colowick, SP, and Caplan, NO, (Eds.), Academy Press, New York, NY, 157, pp 392-394, 678-81.
12. Operator ?s Manuel, Dimension System Dade Behring, 2000.
13. FAQs - Genera. 2008. www.icgp.ie/go/courses/heartwatch/ heartwatch-faqs /FB2EF29C-A12D-9EDA-52E4FE182C061591.html (dostupno 16.mart 2009)
14. Risk Factors. 2006. http://www.apotex.com/ca/en/healthcareprofessionals/ ce/web/dys/PDFFiles/types-and-causespdf (dostupno 16. mart 2009)
15. Lim TO, Selvan A, Suppiah A, Khan N, Ismail F. Comparison of serum fructosamine and blood glucose concentrations as indices of glycaemic control in non-insulin dependent diabetic out patients. Singapore Med J 1992; 33:287-89.
16. Browner WS, Pressman AR, Lui LY, Cummings SR. Association between serum fructosamine and mortality in elderly women. Am J Epidemiol 1999; 149(5):471-75.
17. Baker JR, Metcalf PA, Holdaway IM, Johnson RN. Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus. Br Med J 1985; 290:352-55.
18. American Diabetes Association Position Statement: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. J Am Diet Assoc 2002; 102(1):109-18.
19. Tuomilehto J, Lindstrom J, Eriksson JG. Finnish diabetes prevention study group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impared glucose tolerance. N Engl J Med 2001; 344:1343-50.
20. Gerhard GT, Ahmann AA, Meeuws K, McMurry MP, Duell B, Connor WE. Effects of low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes. Am J Clin Nutr. 2004; 80(3):668-73.
21. Volchegorskii A, Kharchenkova NV. Fructosamine, high density lipoproteins and degree of dyslipidemia in patients with vascular complications of diabetes mellitus type I. Klin Lab Diagn 2003; 1:14-7.
22. Sathiyapriya V, Nandeesha H, Bobby Z, Pavithran P, Selvaraj N, Rattina Dasse N. Insulin resistance and enhanced protein glycation in men with prehypertension.
23. Clin Chem Lab Med 2006; 44(12):1457-61.